PRKD1 and breast cancer: Multiple signaling pathways are essential for angiogenesis and pro-arteriogenic reprogramming of ECs, including lysophosphatidic acid (LPA)/protein kinase D (PKD-1), which may regulate the vascular niche within the TME, in addition to promoting BC progression21–25.